Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.
about
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@ast
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@en
type
label
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@ast
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@en
prefLabel
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@ast
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@en
P2860
P356
P1476
Safety and efficacy of laropip ...... primary hypercholesterolemia.
@en
P2093
Adie Viljoen
P2860
P356
10.2147/DHPS.S7302
P407
P577
2010-05-24T00:00:00Z